James M Frates Sage Therapeutics, Inc. (SAGE) insider trading activity

SAGE Quotes by TradingView

James M Frates is of Sage Therapeutics, Inc.. Currently has a direct ownership of 0 shares of SAGE, which is worth approximately $0. The most recent transaction as insider was on Jul 31, 2025, when has been sold 2,845 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
n/a 3M change
n/a 12M change
Total Value Held $0

JAMES M FRATES Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 31 2025
SELL
Disposition due to a tender of shares in a change of control transaction
-
2,845 Reduced 100.0%
0 Common Stock

Also insider at

AMLX
Amylyx Pharmaceuticals, Inc. Healthcare
Chief Financial Officer
JMF

James M Frates

Cambridge, MA

Track Institutional and Insider Activities on SAGE

Follow Sage Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SAGE shares.

Notify only if

Insider Trading

Get notified when an Sage Therapeutics, Inc. insider buys or sells SAGE shares.

Notify only if

News

Receive news related to Sage Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SAGE